Skip to main content

Advertisement

Open Peer Review Reports for: Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
22 Apr 2013 Submitted Original manuscript
24 Apr 2013 Author responded Author comments - Tomas Buchler
Resubmission - Version 2
24 Apr 2013 Submitted Manuscript version 2
30 Jan 2014 Reviewed Reviewer Report - Bruce Giantonio
11 Feb 2014 Reviewed Reviewer Report - Pilar GarcĂ­a-Alfonso
11 Mar 2014 Author responded Author comments - Tomas Buchler
Resubmission - Version 3
11 Mar 2014 Submitted Manuscript version 3
27 Apr 2014 Author responded Author comments - Tomas Buchler
Resubmission - Version 4
27 Apr 2014 Submitted Manuscript version 4
Publishing
30 Apr 2014 Editorially accepted
7 May 2014 Article published 10.1186/1471-2407-14-323

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement